Periventricular leukomalacia is a brain injury that affects the white matter near the fluid-filled spaces in the brain, and it is seen most often in premature or medically fragile newborns. The early symptoms of periventricular leukomalacia may be hard to spot at first, but later they can include delayed movement, muscle stiffness, feeding problems, vision changes, seizures, or cerebral palsy. Not everyone will have the same experience. Periventricular leukomalacia is usually a lifelong condition, and treatment focuses on supportive care such as physical, occupational, and speech therapy, along with treatment for seizures or other complications when needed. The outlook varies with how much brain tissue was affected, and severe cases can raise the risk of serious disability or death, especially in very ill premature infants.
How many people live with Periventricular leukomalacia?
Worldwide and U.S. estimates for how many people are living with periventricular leukomalacia are not consistently reported by a single authoritative source. Most medical reports give rates in very premature babies instead of a total number of children and adults living with it, and those rates can vary depending on which babies are included and how the brain injury is checked for on scans.
Overview
Periventricular leukomalaciaSymptoms
Periventricular leukomalacia may not be obvious at first. As a child grows, signs can include delayed motor skills, stiff or tight muscles, and sometimes vision problems. Some children also develop cerebral palsy or seizures.
Outlook and prognosis
The outlook for periventricular leukomalacia varies with how much white matter injury occurred. Many children have mild movement or learning challenges, while others develop cerebral palsy, vision problems, or seizures and need long-term therapy and support.
Causes and risk factors
Periventricular leukomalacia is linked to reduced blood flow or oxygen to a baby's brain around birth. Risk is higher with prematurity, very low birth weight, severe infection, and inflammation. Maternal infection can also raise risk.
Genetic influences
Genetics are not thought to be a main cause of periventricular leukomalacia. Periventricular leukomalacia is usually linked more to early birth, inflammation, and reduced oxygen or blood flow, though genetic variations may slightly affect risk or recovery in some babies.
Diagnosis
Periventricular leukomalacia is diagnosed with brain imaging, usually cranial ultrasound in newborns and sometimes MRI for a clearer view. Doctors also look at pregnancy, birth, and newborn history, plus exam findings, to support the diagnosis.
Treatment and drugs
Periventricular leukomalacia treatment focuses on supporting movement, feeding, learning, and vision as a child grows. Many with periventricular leukomalacia benefit from physical, occupational, and speech therapy. Some also need medicines for muscle stiffness or seizures, plus regular developmental follow-up.
Symptoms
Some babies with Periventricular leukomalacia seem well at first, and the effects become clearer as movement and learning skills are expected to develop. You might notice small changes at first, such as delayed rolling, unusual stiffness, or trouble using the legs smoothly. The early symptoms of Periventricular leukomalacia can range from mild developmental delays to more significant problems with movement, vision, learning, feeding, or seizures.
Babies may take longer to hold up the head, roll, sit, crawl, or walk. In daily life, this can mean needing more support during play and reaching milestones later than expected.
Some babies seem floppy at first, while others later develop tight, stiff muscles, especially in the legs. Diaper changes, dressing, standing, or stretching the legs may become harder.
As children grow, walking may look unsteady, on the toes, or with the legs crossing inward. Some may tire easily, fall more often, or need braces, walkers, or physical therapy. In some children, this is part of cerebral palsy.
Fine motor tasks can be harder, including reaching for toys, stacking blocks, buttoning clothes, or later writing. Some children also have slower, less precise hand movements that make daily tasks frustrating.
How people usually first notice Periventricular leukomalacia?
Periventricular leukomalacia is usually first noticed in babies who were born early or had a complicated newborn course, often after doctors see concerns such as low muscle tone, unusual stiffness, pauses in breathing, feeding trouble, or slower-than-expected movement and development. In many cases, families do not spot a clear warning sign right away because the injury affects deep white matter in the brain and may first show up on a head ultrasound or MRI done in the neonatal intensive care unit. As children grow, the first signs of periventricular leukomalacia can become easier to recognize if a baby is not meeting motor milestones, seems to favor one side, or later develops tight muscles or coordination problems.
Types of Periventricular leukomalacia
Periventricular leukomalacia can affect daily life very differently from one child to another, depending on how much of the brain’s white matter is injured and what pattern that injury takes. In practice, the main types of periventricular leukomalacia are usually described by what brain scans show, and that often helps explain why movement, learning, vision, or muscle tone may vary. Symptoms don’t always look the same for everyone.
Cystic PVL
This type causes small fluid-filled areas where white matter has been damaged, and it is usually the more severe form. Babies and children with cystic periventricular leukomalacia are more likely to have clear motor problems, including tight muscles, delayed movement skills, or cerebral palsy. Difficulties with vision, learning, or development can also occur.
Diffuse PVL
This type involves more widespread thinning or injury of the white matter without the larger cysts seen on scans. Symptoms can be subtler at first, so some children are noticed later when delays in movement, attention, learning, or coordination become clearer. Even within this form, severity can range from mild to more significant.
Can I slow down the onset of symptoms?
Usually no; once periventricular leukomalacia has happened, there is no proven lifestyle change or medicine that can meaningfully delay when symptoms begin, because they come from an early injury to the brain rather than a condition that can be held off later. What does help is close follow-up and early support, such as therapy for movement, daily skills, and speech, along with prompt care for related problems like vision, hearing, feeding, or seizures, but that can improve function and comfort rather than prevent or delay the condition itself. Regular developmental checkups are the main medical step, and while research is ongoing, early support can still make a meaningful difference in day-to-day life without promising a later onset of symptoms.
What genetics can tell you about symptoms
For periventricular leukomalacia, genetics usually cannot tell doctors exactly which symptoms will happen, how severe they will be, or when they will start. In most cases, symptoms depend much more on how much white matter injury occurred, how early a baby was born, and other medical stresses around birth, so many living with this condition can have very different outcomes. Researchers are studying whether inherited differences may slightly affect how vulnerable the developing brain is to injury or inflammation, but this is not yet reliable for predicting symptoms in everyday care.
Causes and risk factors
Periventricular leukomalacia is much more likely in babies born very early, especially those with very low birth weight. The main risk factors for periventricular leukomalacia are reduced blood flow or oxygen to the brain around birth and serious illness in the newborn period. Infections and inflammation during pregnancy or after delivery can also raise the risk, along with bleeding in the brain, low blood pressure, or severe breathing problems. Unlike some conditions, it is usually not caused by a single inherited gene change, and researchers are still learning how these pieces fit together. Some pregnancy exposures, such as smoking, may increase the chance of premature birth, which can then increase the risk of periventricular leukomalacia.
What are the most common causes or risk factors?
Periventricular leukomalacia most often affects babies born very early, especially those with very low birth weight, because the area of the brain that carries signals is still very fragile and can be hurt if it does not get enough oxygen or blood flow. The main risk factors are prematurity, problems around birth that reduce oxygen, severe illness with unstable blood pressure or breathing, and infection or inflammation in the mother, placenta, or baby. There is no single common inherited cause, and genes are not thought to be a major risk factor in most cases.
Environmental and biological risk factors
Periventricular leukomalacia is a type of white matter brain injury seen most often in babies born very early or who become very sick around birth. The main risk factors for periventricular leukomalacia relate to how vulnerable the developing brain is and whether it faces low oxygen, reduced blood flow, or inflammation. Doctors often group risks into internal (biological) and external (environmental).
Babies born very early have the highest risk because the white matter near the brain’s fluid spaces is still immature and easily injured. The risk rises further in infants with very low birth weight, especially under 1.5 kg (3.3 lb).
When the brain gets too little oxygen, its most fragile white matter can be injured. This can happen during a difficult delivery or with serious breathing problems after birth.
The preterm brain is sensitive to drops or rapid changes in blood pressure and blood flow. Repeated instability can raise the chance of periventricular leukomalacia.
Infection in the mother, placenta, or newborn can trigger inflammation that damages developing brain tissue. Examples include chorioamnionitis before birth and sepsis after birth.
Genetic risk factors
For most families, periventricular leukomalacia is not caused by one clearly inherited gene change. The genetic risk factors for periventricular leukomalacia are still being studied, and genetics seems to play more of a supporting role than a sole cause. Researchers think inherited differences in inflammation, blood flow, clotting, and cell protection may slightly change how vulnerable a baby’s white matter is. Carrying a genetic change doesn’t guarantee the condition will appear.
Single-gene cause: Periventricular leukomalacia is usually not passed down as a classic single-gene condition. In most babies, no single inherited change fully explains why the white matter injury developed.
Inflammation genes: Inherited differences in genes that control inflammation may affect how strongly the developing brain reacts to stress around birth. This may slightly change susceptibility to white matter injury, especially in very preterm infants.
Clotting disorders: Some inherited clotting tendencies may affect blood flow before or around birth. They have been studied as possible contributors to periventricular leukomalacia, but the link is not consistent in every study.
Blood-flow genes: Variants in genes that help regulate blood vessel tone may influence how steady blood flow is in the immature brain. Because this area is delicate, even short changes in flow may matter more in some babies than in others.
Oxidative stress: Genes involved in protecting cells from oxidative stress may also play a part. These inherited differences are thought to modify risk rather than directly cause periventricular leukomalacia on their own.
Family history: Most families do not show a strong inherited pattern of periventricular leukomalacia from one pregnancy to the next. Still, a family history of clotting disorders or rare neurologic conditions may lead doctors to look more closely for a genetic contributor.
Lifestyle risk factors
There are only a few direct lifestyle-related contributors to periventricular leukomalacia. Most cases are driven by prematurity and serious medical problems around birth, but some maternal habits can increase the chance of complications that make this brain injury more likely. When people ask about lifestyle risk factors for periventricular leukomalacia, the best-supported factors are smoking, alcohol or drug exposure, poor nutrition, and inconsistent prenatal self-care.
Smoking during pregnancy can reduce oxygen delivery to the fetus and increase the risk of preterm birth. Both low oxygen states and prematurity are major pathways linked to periventricular leukomalacia.
Alcohol use in pregnancy can disrupt fetal brain development and raise the risk of pregnancy complications. Heavy or repeated exposure may also increase the chance of premature delivery, which is strongly associated with periventricular leukomalacia.
Cocaine, methamphetamine, opioids, and other non-prescribed drugs can affect placental blood flow and increase fetal stress. They are also linked to preterm birth and medical instability around delivery, which can raise the risk of periventricular leukomalacia.
Inadequate nutrition during pregnancy can contribute to poor fetal growth and reduced resilience during a high-risk birth. Low overall nutritional status may also increase vulnerability to infection and other complications tied to periventricular leukomalacia.
Risk prevention
Periventricular leukomalacia is a brain injury most often linked to problems around a very early birth, so prevention mainly focuses on lowering those risks before and during delivery and protecting a newborn’s brain right after birth. For families, this often means careful prenatal care, prompt treatment of pregnancy complications, and expert care in a neonatal intensive care unit if a baby arrives early. Prevention is about lowering risk, not eliminating it completely.
Regular pregnancy visits can help spot problems such as high blood pressure, infection, or poor fetal growth before they become more serious. Treating these issues early may lower the chance of very preterm birth, which is one of the main risks for periventricular leukomalacia.
When possible, reducing the chance of early delivery is one of the best ways to lower risk. This can include managing chronic health conditions, avoiding smoking and substance use during pregnancy, and getting urgent care for symptoms like contractions, bleeding, or leaking fluid.
Infections during pregnancy or around delivery can raise inflammation and stress on a baby’s brain. Quick treatment of suspected maternal or newborn infection may help reduce the risk of periventricular leukomalacia.
If preterm delivery seems likely, steroid medicine given during pregnancy can help the baby's lungs and may also lower some complications linked with prematurity. This step is time-sensitive, so it is usually guided by the obstetric team.
Can you prevent Periventricular leukomalacia?
Periventricular leukomalacia cannot always be prevented, especially because it most often happens in very premature babies who are already very vulnerable. Good pregnancy care, lowering the chance of very early birth when possible, and quickly treating infections or other serious problems during pregnancy or after birth may help reduce the risk. Even with excellent care, some babies still develop it, so prevention is only partly possible.
Transmission
Periventricular leukomalacia is not contagious, so it cannot be passed from one baby, child, or adult to another through contact, الهواء, food, or body fluids. It is also not considered an inherited disorder in most cases, so when families ask about how periventricular leukomalacia is inherited, the usual answer is that there is no known genetic transmission of periventricular leukomalacia from parent to child.
Instead, periventricular leukomalacia usually develops because the brain is injured before birth or around the time of birth, most often in babies born very early or after problems that affect blood flow, oxygen, or inflammation. An infection during pregnancy can sometimes raise the risk of this kind of brain injury, but that does not mean periventricular leukomalacia itself is infectious.
When to test your genes
For periventricular leukomalacia, genetic testing is not usually part of early detection because this condition is most often linked to brain injury around premature birth, not an inherited gene change. Testing may be considered if the pattern is unusual, symptoms are broader than expected, or your care team suspects another neurologic or genetic condition that could change treatment or counseling.
Diagnosis
Periventricular leukomalacia can affect movement, muscle control, learning, vision, and overall development, so the first clue is often that a baby or young child is not meeting expected milestones. Doctors usually begin with the pregnancy and birth history, a careful exam, and brain imaging to look for signs of injury in the white matter near the fluid-filled spaces of the brain. Because some changes do not show up right away, the diagnosis of periventricular leukomalacia may take more than one visit or scan.
Doctors ask about prematurity, low birth weight, infection, bleeding in the brain, and other problems around the time of birth. They also look for muscle stiffness, unusual floppiness, feeding trouble, delayed milestones, or vision concerns that can point toward periventricular leukomalacia.
In newborns, especially babies born early, ultrasound through the soft spot is often the first imaging test. It can show areas of injury or cysts near the ventricles, although mild changes may be missed early on.
MRI gives a clearer picture of white matter injury and is often the best test to confirm how periventricular leukomalacia is diagnosed. It can show both older damage and more subtle changes that ultrasound may not fully capture.
Some babies need follow-up scans because the injury can become easier to see over time. Tests may feel repetitive, but each one helps rule out different causes.
How is Periventricular leukomalacia diagnosed?
Periventricular leukomalacia is usually diagnosed with brain scans in babies who were born early or had a difficult start around birth. Doctors often begin with an ultrasound through the baby’s soft spot and may use an MRI, a more detailed scan, to look for damage in the brain tissue that carries signals, especially near the fluid-filled spaces in the middle of the brain. The diagnosis is based on those scan findings along with the baby’s medical history, physical exam, and follow-up checks of movement and development.
Stages of Periventricular leukomalacia
Periventricular leukomalacia does not have defined progression stages. This is because it is usually a brain injury that happens around birth, rather than an illness that steadily moves from one stage to the next over time. Often the process begins when you notice changes in daily life, such as a baby feeling unusually stiff, missing movement milestones, or later showing signs linked to the early symptoms of periventricular leukomalacia. Doctors usually diagnose and monitor periventricular leukomalacia using brain imaging such as ultrasound or MRI, along with regular checks of movement, muscle tone, development, vision, and learning as a child grows.
Outlook and prognosis
Outlook in periventricular leukomalacia varies widely and depends on how much white matter injury occurred, how early it happened, and whether there were other complications of prematurity. Mild cases may lead to subtle motor, learning, attention, or visual difficulties, while more severe injury is associated with cerebral palsy, developmental delay, intellectual disability, epilepsy, and long-term feeding or respiratory problems. The brain can make some developmental gains over time, especially with early physical, occupational, speech, and vision support, but the injury itself does not reverse. Survival is usually determined less by the brain lesion alone than by the infant’s overall prematurity and associated medical problems; among survivors, disability can range from minimal to profound. Mortality is higher in the sickest and most premature infants, particularly when periventricular leukomalacia occurs alongside severe infection, lung disease, or bleeding in the brain. Long-term follow-up is important because some difficulties do not become fully apparent until later infancy or school age.
Long-term effects
Periventricular leukomalacia can affect movement, learning, and everyday development over time, but the outlook is not the same for everyone. Some children have mild lasting challenges, while others have more significant disability that continues into adult life. The long-term effects of periventricular leukomalacia depend largely on how much brain tissue was injured and whether other problems linked to premature birth are also present. Long-term effects vary widely, and some may become clearer as a child grows and misses expected milestones.
Many children with periventricular leukomalacia develop muscle stiffness or poor coordination, especially in the legs. Over time, this can affect crawling, walking, balance, and fine motor tasks such as holding a spoon or buttoning clothes.
Periventricular leukomalacia is a common cause of cerebral palsy, particularly forms that mainly affect leg movement. For many, this can mean a long-term need for help with mobility, posture, or daily physical tasks.
Some children later have trouble with attention, processing speed, memory, or school-based skills. These difficulties may be mild at first and become more noticeable when learning demands increase.
Language and communication can develop more slowly in some children with periventricular leukomalacia. This may include delayed first words, trouble expressing needs clearly, or ongoing speech differences.
How is it to live with Periventricular leukomalacia?
Living with periventricular leukomalacia can look very different from one child to another, because the injury affects the brain’s white matter, which helps signals travel smoothly, and that can influence movement, muscle tone, learning, vision, or development. For many families, daily life may include physical, occupational, or speech therapy, extra medical visits, and routines built around mobility, communication, or school support, while some children have milder challenges and others need much more hands-on help. This often shapes life for parents, siblings, and caregivers too, bringing added stress, planning, and emotional weight, but with early support, rehabilitation, and community resources, many children and families find ways to build strong routines and meaningful, connected lives.
Treatment and drugs
Periventricular leukomalacia can affect movement, muscle tone, learning, and vision, so treatment usually focuses on helping with day-to-day function rather than reversing the brain injury itself. Treatment plans often combine several approaches, including physical, occupational, and speech therapy to support motor skills, feeding, communication, and development. Some children with periventricular leukomalacia also need medicines to ease symptoms such as muscle stiffness, seizures, or pain, and care may involve specialists in child development, neurology, rehabilitation, and vision. Early treatment for periventricular leukomalacia often gives the best chance to build skills over time, although needs can vary a lot from one child to another. Support from family or friends can make daily treatment easier, especially when exercises, appointments, and school supports become part of the weekly routine.
Can you cure Periventricular leukomalacia?
No, periventricular leukomalacia cannot be cured because it is a type of brain injury, and the damage that has already happened cannot be undone. Treatment focuses on helping children do as well as possible with early support such as physical, occupational, and speech therapy, along with medicines or other care if problems like muscle stiffness or seizures happen. Many children living with this condition can make progress with the right support, but the condition itself does not go away.
Non-drug treatment
Periventricular leukomalacia can affect movement, learning, feeding, speech, vision, and daily independence, so care usually centers on therapies that build skills over time. Treatment is tailored to each child’s strengths and challenges, and it often starts early so the brain and body can practice healthier patterns as they grow. Supportive therapies can improve comfort, mobility, communication, and participation at home, in school, and in the community. Not every approach works the same way, so many living with periventricular leukomalacia use a mix of therapies that changes with age and needs.
Physical therapy for periventricular leukomalacia helps children work on muscle strength, balance, posture, and walking. It can also reduce tight movement patterns and make everyday tasks like sitting, standing, or getting across a room feel more manageable. Stretching, guided practice, and play-based exercises are often part of the plan.
Occupational therapy focuses on hand use, dressing, bathing, writing, and other daily skills. Therapists may also help with body positioning, sensory challenges, and finding easier ways to manage school or home routines.
Speech and language therapy can support talking, understanding, social communication, and safe swallowing. For children who have trouble eating or drinking, feeding therapy may help with chewing, coordination, and reducing choking risk.
Early intervention programs bring therapy and developmental support into the first years of life, when practice can make a big difference. For many, treatment begins not at the pharmacy, but with guided play, parent coaching, and regular skill-building at home.
Your genes may have an impact on how drugs work for you
For people living with periventricular leukomalacia, there is no well-established evidence that inherited genetic differences clearly change how the condition itself is treated with medicines, because care usually focuses on symptoms like muscle stiffness, movement problems, or seizures rather than a single drug for the brain injury. In day-to-day life, this means treatment is usually adjusted by watching how well a child responds and whether side effects show up, such as extra sleepiness or trouble feeding, not by genetic testing. Genetic testing to guide medicine choice is not a routine part of care for this condition at this time.
Pharmacological treatments
Daily life with periventricular leukomalacia often centers on managing movement problems, seizures, pain, feeding issues, or breathing symptoms rather than treating the brain injury itself. There is no medicine that reverses periventricular leukomalacia, but several drugs can help with specific symptoms and improve comfort and function. Not everyone responds to the same medication in the same way. The medicines used depend on a child or adult’s symptoms, age, and any related conditions such as cerebral palsy or epilepsy.
If periventricular leukomalacia causes seizures, doctors may use anti-seizure drugs such as levetiracetam, phenobarbital, valproate, oxcarbazepine, or topiramate. The best choice depends on age, seizure type, and side effects, and some people may need changes over time.
Baclofen is commonly used for muscle stiffness and spasms, which are common in people with periventricular leukomalacia. It can help relax tight muscles, but it may also cause sleepiness or weakness, so dosing is usually adjusted carefully.
Diazepam or tizanidine may be used when muscle spasms are especially troublesome, such as when dressing, bathing, or sleep becomes difficult. These medicines can help short term or alongside other treatments, but they may cause drowsiness.
Botulinum toxin injections can be used for focal spasticity, meaning stiffness in a specific muscle group such as the calf, hamstring, or arm. For many families looking into medications for periventricular leukomalacia, this is often part of treatment for muscle stiffness rather than a whole-body medicine.
Genetic influences
When a baby is diagnosed with periventricular leukomalacia, many families want to know whether it happened because of something inherited. In most cases, periventricular leukomalacia is linked more strongly to premature birth, infection or inflammation around birth, and problems with oxygen or blood flow than to a single gene passed down through a family. Genetics is only one piece of the puzzle, but genes involved in inflammation, blood clotting, and how the developing brain responds to stress may help explain why some babies are more vulnerable than others. That means genetics may play a small part in the risk factors for periventricular leukomalacia, even though it is not usually considered a directly inherited disorder. For most families, routine genetic testing is not a standard part of diagnosing periventricular leukomalacia unless there are other signs that suggest a separate genetic condition.
Is Periventricular leukomalacia genetic?
Genetics are not thought to be a main cause of periventricular leukomalacia. Periventricular leukomalacia is usually linked more to early birth, inflammation, and reduced oxygen or blood flow, though genetic variations may slightly affect risk or recovery in some babies.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of being human. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, one well-understood variant in a particular gene is enough to establish the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many families, treatment decisions in periventricular leukomalacia are shaped more by everyday needs, such as stiffness, seizures, feeding trouble, or delayed development, than by a specific genetic result. Periventricular leukomalacia is usually managed with therapies and symptom-based medicines, and there is no standard drug that directly reverses the white matter injury itself. Genetics is only one factor, and for most children with periventricular leukomalacia, genetic testing does not routinely determine which medicines are used. Instead, doctors usually choose treatments based on the child’s symptoms, age, other health conditions, and how they respond over time.
In some cases, testing may be considered if the overall picture suggests an additional inherited condition or another cause for seizures, muscle tightness, or developmental differences. Genetic differences can also affect how some children process medicines such as anti-seizure drugs, but this is not yet a standard part of care for periventricular leukomalacia. If families are wondering how genetics affect treatment for periventricular leukomalacia, the short answer is that genetics may occasionally add useful clues, but day-to-day treatment is still mainly guided by symptoms and careful follow-up.
Interactions with other conditions
For many families, the bigger day-to-day issue is not periventricular leukomalacia on its own, but how it can sit alongside other health problems linked to premature birth. Doctors call it a comorbidity when two conditions occur together. Many living with periventricular leukomalacia also have a higher chance of movement problems such as cerebral palsy, developmental delay, feeding difficulties, or seizures, and these can affect one another over time. For example, a child who already has muscle stiffness may find feeding or sleep harder, while seizures can make learning and recovery more challenging. Periventricular leukomalacia may also occur with vision or hearing problems, especially in babies who had a very early or medically complex start to life, so checking all areas of development matters. When people ask about the long-term effects of periventricular leukomalacia, the answer often depends not just on the brain injury itself but on whether other conditions are present and how early support begins.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Periventricular leukomalacia?
Other conditions that can look like periventricular leukomalacia include other kinds of brain injury around birth, especially not getting enough oxygen, bleeding in the brain in a premature baby, or a stroke. Brain infections and some genetic conditions can also cause similar problems, such as delayed development, stiff or weak muscles, trouble with movement, or vision issues.
History
Periventricular leukomalacia has been recognized more clearly as newborn care has improved and more very premature babies have survived the first difficult days of life. In the past, some infants later developed movement, learning, or vision problems without anyone fully understanding why. When families noticed a child was unusually stiff, delayed in sitting or walking, or struggled with vision, the connection to an early brain injury was often missed.
In recent decades, awareness has grown as doctors began linking those later challenges to a specific pattern of injury in the brain’s white matter, especially around the fluid-filled spaces called ventricles. Early descriptions came mainly from autopsy findings in very small or medically fragile newborns. Over time, descriptions became more precise as ultrasound, and later MRI, allowed doctors to see these changes during life rather than only after death.
That shift mattered in everyday care. It helped neonatal teams watch high-risk babies more closely, explain possible outcomes to families, and start early support when needed. Not every baby with periventricular leukomalacia has the same course, but the condition became an important part of understanding why some premature infants later show early symptoms of periventricular leukomalacia such as tight muscles, delayed motor milestones, or feeding difficulties.
The history of periventricular leukomalacia also reflects a broader change in medicine: moving from simply describing symptoms to understanding patterns of brain development and injury in newborns. Researchers later identified that this condition is tied to damage affecting the developing white matter, and that risk is highest in babies born very early or with serious medical complications around birth. Today, that history helps guide earlier diagnosis, closer follow-up, and better support for children and families living with the long-term effects.